PACS Group (PACS) Stock Forecast & Price Target
$7.92B
Market Cap
28.86
P/E
20.48
Forward P/E
49
Score
PACS price $49.99 +0.93 +1.90%
Stocklytics score rationale: value 38, quality 36, growth 74.
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1166563000 | 2421994000 | 3111492000 | 4089734000 | 5288932000 |
PACS Group, Inc. operates as a holding company, primarily focused on delivering post-acute healthcare services. This encompasses operating various facilities, providing skilled professionals, and offering essential ancillary support. The company further specializes in providing a spectrum of senior living options, encompassing dedicated senior care, assisted living, and independent living residences in select…
Consensus Buy from 6 analysts. Average price target $56.67, +13.4% versus the current price. Low $48.00. High $62.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $56.67 for PACS Group (PACS), 13.7% above the current price of $49.85. Of 6 analysts covering the stock, 6 rate it Buy or Strong Buy, 0 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $48.00 |
|---|---|
| Average | $56.67 |
| High | $62.00 |
The average is 13.7% above the current price of $49.85.
Of 6 analysts, 6 rate PACS Group Buy or Strong Buy, 0 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
Analyst averages on file: 2026, EPS $2.44, revenue $5.85 billion. 2027, EPS $2.70, revenue $6.54 billion.
The Stocklytics Score for PACS is 49 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$56.67 average, with a published range of $48.00 to $62.00.
The consensus is Buy from 6 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $2.44. The average revenue estimate is $5.85 billion.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: PACS Group · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$7.92B
Market Cap
28.86
P/E
20.48
Forward P/E
49
Score